The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure
NCT03064542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2023-05-25
Summary
To determine how thyroid status regulates the relationship between brown adipose tissue (BAT) volume/activity, white adipose tissue (WAT) partitioning and basal metabolic rate (BMR) in hyperthyroid patients transitioning to euthyroidism via antithyroid drugs.
To compare euthyroid outcomes (BAT, WAT, BMR, body composition, body weight and insulin resistance) achieved by hypothalamus-pituitary-thyroid (HPT) set point vs. normal ranges of plasma free thyroxine 4 (FT4) and throxine stimulating hormone (TSH).
Conditions
- Hyperthyroidism
Interventions
- DRUG
-
carbimazole (CMZ) or thiamazole (TMZ)
CMZ or TMZ will be used to treat the hyperthyroidism till the FT4/TSH is in normal range.
Sponsors & Collaborators
-
Agency for Science, Technology and Research
collaborator OTHER -
Singapore Institute of Food and Biotechnology Innovation
lead OTHER_GOV
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-13
- Primary Completion
- 2023-05-19
- Completion
- 2023-05-19
Countries
- Singapore
Study Locations
More Related Trials
-
Energy Metabolism in Thyroidectomized Patients
NCT04782856 ·Status: COMPLETED ·Phase: PHASE2
-
Thyroid and Glucose and Energy Metabolism
NCT00106119 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Methimazole Dosing Algorithm
NCT05964452 ·Status: TERMINATED
-
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
NCT06345339 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition
NCT02891668 ·Status: COMPLETED
-
Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration
NCT00196729 ·Status: COMPLETED ·Phase: PHASE3
-
Hypothyroidism, Metabolism and Food Intake
NCT02993562 ·Status: COMPLETED
-
Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
NCT01739972 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT06727604 ·Status: RECRUITING ·Phase: PHASE2
-
The Interaction Between Resting Metabolic Rate, Physical Activity and Thyroid Hormone in Females
NCT06377943 ·Status: COMPLETED
-
Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter
NCT00454220 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease
NCT07129642 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
NCT06961084 ·Status: RECRUITING ·Phase: PHASE2
-
Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma
NCT06325787 ·Status: COMPLETED ·Phase: NA
-
Thyroid and Fat Tissue Metabolism
NCT00312715 ·Status: COMPLETED
-
Thiamine Supplement in Patients With Severe Hyperthyroidism
NCT02767245 ·Status: COMPLETED ·Phase: NA
-
Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry
NCT05299437 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
NCT06275373 ·Status: RECRUITING
-
Effects of L-carnitine on Hypothyroidism
NCT01769157 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of T3 Therapy in Patients With Hypothyroidism
NCT01800617 ·Status: COMPLETED ·Phase: PHASE2
-
Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid
NCT05501041 ·Status: ENROLLING_BY_INVITATION
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT07018323 ·Status: RECRUITING ·Phase: PHASE2
-
Thyroid Study Type 2 Diabetes Mellitus (T2DM)
NCT01379170 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis
NCT05118542 ·Status: COMPLETED ·Phase: PHASE3